ArticleCNS neuroscience & therapeutics2025
Analysis of Two Neuroanatomical Subtypes of Parkinson's Disease and Their Motor Progression Based on Semi-Supervised Machine Learning.
Article in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe high heterogeneity of Parkinson's disease (PD) hinders personalized interventions. Brain structure reflects damage and neuroplasticity and is one of the biological bases of symptomatology. Subtyping PD in the framework of brain structure helps in the prediction of disease trajectories and optimizes treatment strategies.
methodsThe study included a total of 283 de novo PD and 141 healthy controls (HC). Structural heterogeneity between PD and HC was compared, and patients were classified using Heterogeneity through Discriminative Analysis. Gray matter volume (GMV), clinical symptoms, and substantia nigra free water (SNFW) among all subtypes were compared. These subtypes were followed for an average of 2.5 years to monitor motor impairment.
resultsEarly PD patients possessed higher GMV heterogeneity than HC, and two subtypes based on GMV patterns were identified. Subtype 1 showed widespread GMV reductions, while subtype 2 had an increased volume in the basal ganglia and parts of the cortex. Subtype 1 had more severe motor and non-motor symptoms, as well as higher posterior SNFW. The whole-brain GMV in the PD group was negatively correlated with posterior SNFW; basal ganglia volume in subtype 1 was negatively correlated with Unified Parkinson's Disease Rating Scale (UPDRS)-III scores, whereas no linear correlation was found in subtype 2. The UPDRS-III progression rate was higher in subtype 1 than in subtype 2 (2.52 vs 0.92 points/year).
conclusionThe heterogeneity of PD patients reflected the changes in their brain structure. The identification of these changes helps the classification of patients into different subtypes, additionally supported by clinical manifestations and SNFW, with consequent benefits for clinical consultancy and precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.